NGL Fine-Chem
Ticker >

NGL Fine-Chem share price

NGL Fine-Chem Ltd.

NSE: NGLFINE BSE: 524774 SECTOR: Pharmaceuticals & Drugs  39k   252   38

2710.95
+86.30 (3.29%)
NSE: Today, 04:03 PM

Price Summary

Today's High

₹ 2823.9

Today's Low

₹ 2615.1

52 Week High

₹ 2699.75

52 Week Low

₹ 1400

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1674.83 Cr.

Enterprise Value

₹ 1694.38 Cr.

No. of Shares

0.62 Cr.

P/E

46.27

P/B

6.65

Face Value

₹ 5

Div. Yield

0.06 %

Book Value (TTM)

₹  407.79

CASH

₹ 12.95 Cr.

DEBT

₹ 32.5 Cr.

Promoter Holding

72.74 %

EPS (TTM)

₹  58.59

Sales Growth

-13.69%

ROE

9.31 %

ROCE

11.5%

Profit Growth

-61.49 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-13.69%
3 Year21.81%
5 Year19.33%

Profit Growth

1 Year-61.61%
3 Year24.49%
5 Year9.67%

ROE%

1 Year9.31%
3 Year27.13%
5 Year23.38%

ROCE %

1 Year11.5%
3 Year32.7%
5 Year27.88%

Debt/Equity

0.1441

Price to Cash Flow

52.53

Interest Cover Ratio

15.5544977019041

CFO/PAT (5 Yr. Avg.)

0.647994129278072

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 72.74 0
Dec 2023 73.06 0
Sep 2023 73.06 0
Jun 2023 73.53 0
Mar 2023 73.53 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.7983665506064% for the Past 3 years.
  • The company has shown a good revenue growth of 21.8103748093056% for the Past 3 years.
  • Company has been maintaining healthy ROE of 27.1336564614143% over the past 3 years.
  • Company has been maintaining healthy ROCE of 32.7020613287783% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 15.5544977019041.
  • The company has an efficient Cash Conversion Cycle of 74.0335132365481 days.
  • Company has a healthy liquidity position with current ratio of 2.81004455459527.
  • The company has a high promoter holding of 72.74%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.05159351440522.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 69.8 72.94 69.11 79.44 84.81
Total Expenditure 62.37 62.31 61.51 66.31 73.86
Operating Profit 7.43 10.64 7.6 13.13 10.95
Other Income 2.95 2.69 3.8 3.76 4.19
Interest 0.26 0.32 0.24 0.36 0.28
Depreciation 2 1.92 2 2.02 2.07
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.12 11.08 9.16 14.52 12.8
Tax 2.03 2.55 1.36 3.55 3.9
Profit After Tax 6.09 8.53 7.81 10.97 8.9
Adjusted EPS (Rs) 9.86 13.81 12.64 17.75 14.4

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 153.17 152.18 258.18 318.67 275.05
Total Expenditure 120.88 131.27 181.13 252.75 246.34
Operating Profit 32.3 20.91 77.05 65.92 28.71
Other Income 4.12 3.34 8.55 12.64 7.61
Interest 2.55 2.62 2.2 1.91 1.83
Depreciation 6.3 7.27 7.39 7.67 7.9
Exceptional Items 0 0 0 0 0
Profit Before Tax 27.57 14.35 76 68.97 26.6
Tax 7.44 3.75 20.53 16.73 6.48
Net Profit 20.13 10.39 55.33 52.19 20.04
Adjusted EPS (Rs.) 32.58 17.16 89.79 84.57 32.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 3.09 3.09 3.09 3.09 3.09
Total Reserves 89.03 98.12 152.36 203.48 222.43
Borrowings 8.01 8.32 6.13 3.44 2.07
Other N/C liabilities 3.89 3.26 5 4.6 3.87
Current liabilities 45.18 42.79 39.21 63.12 56.65
Total Liabilities 149.21 155.58 205.8 277.72 288.11
Assets
Net Block 60.94 60.85 57.53 58.68 59.49
Capital WIP 0 0 0.91 6.31 26.31
Intangible WIP 0 0 0 0 0
Investments 0 3.73 3.73 3.73 3.73
Loans & Advances 1.81 8.35 20.17 36.4 35.01
Other N/C Assets 0.04 0.01 0 2.57 4.39
Current Assets 86.41 82.65 123.47 170.04 159.19
Total Assets 149.21 155.58 205.8 277.72 288.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 27.57 14.35 76 68.97 26.6
Adjustment 7.87 11 3.25 6.63 5.91
Changes in Assets & Liabilities -19.15 -1.98 -32.15 -43.06 5.86
Tax Paid -7.44 -3.75 -20.53 -16.73 -6.48
Operating Cash Flow 8.85 19.62 26.57 15.82 31.89
Investing Cash Flow -9.54 -18.78 -23.79 -16.13 -23.62
Financing Cash Flow 0 -1.3 -1.08 -1.08 -1.08
Net Cash Flow -0.7 -0.46 1.71 -1.4 7.19

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 73.53 73.53 73.06 73.06 72.74
ajita nachane 11.55 11.55 11.55 11.55 11.55
pci ferrmone chemicals (i... 8.38 - 8.38 8.38 8.38
rahul nachane 17.54 17.54 17.54 17.54 17.54
rajesh lawande 21.89 21.89 21.89 21.89 21.89
sunita potdar 14.18 14.18 13.70 13.70 13.38
pci ferrmone chemicals (i... - 8.38 - - -
pci ferrmone chemicals (i... 8.38 - 8.38 8.38 8.38
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 26.47 26.47 26.94 26.94 27.26
debashish neogi - - - - 1.10
llp 0.03 0.03 0.03 0.03 0.03
debashish neogi 1.01 1.10 1.10 1.10 -
yashkumar poonamchand gol... - - - 1.05 -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

NGL Fine-Chem submits postal ballot notice 19 Mar 2024, 11:08AM NGL Fine-Chem informs about board meeting 11 Mar 2024, 5:09PM NGL Fine-Chem - Quaterly Results12 Feb 2024, 7:04PM NGL Fine-Chem - Quaterly Results12 Feb 2024, 7:04PM NGL Fine-Chem informs about board meeting 3 Feb 2024, 11:54AM Ngl Fine-Chem informs about loss of share certificate16 Jan 2024, 5:25PM NGL Fine-Chem informs about issuance of letter of confirmation1 Jan 2024, 12:22PM NGL Fine-Chem informs about investor presentation17 Nov 2023, 2:25PM NGL Fine-Chem - Quaterly Results10 Nov 2023, 6:57PM Ngl Fine-Chem informs about investor meet8 Nov 2023, 4:30PM NGL Fine-Chem informs about closure of trading window28 Sep 2023, 2:35PM NGL Fine-Chem informs about disclosure 18 Sep 2023, 10:27AM NGL Fine-Chem informs about disclosure 13 Sep 2023, 2:02PM NGL Fine-Chem informs about disclosure11 Sep 2023, 1:16PM NGL Fine-Chem informs about disclosure 8 Sep 2023, 5:20PM NGL Fine-Chem - Quaterly Results4 Aug 2023, 7:17PM NGL Fine-Chem - Quaterly Results4 Aug 2023, 7:17PM NGL Fine-Chem informs about details of loss of certificate28 Jul 2023, 4:29PM NGL Fine-Chem informs about credit rating 18 Jul 2023, 2:19PM NGL Fine-Chem informs about closure of trading window28 Jun 2023, 4:40PM NGL Fine-Chem informs about details of loss of certificate6 Jun 2023, 12:31PM NGL Fine-Chem - Quaterly Results15 May 2023, 6:24PM NGL Fine-Chem - Quaterly Results15 May 2023, 6:24PM NGL Fine-Chem informs about conference call12 May 2023, 3:31PM NGL Fine-Chem informs about certificate19 Apr 2023, 4:23PM NGL Fine-Chem informs about disclosure22 Mar 2023, 12:33PM Ngl Fine-Chem informs about loss of share certificate16 Mar 2023, 4:57PM Ngl Fine-Chem informs about disclosure25 Feb 2023, 3:41PM NGL Fine-Chem informs about disclosure25 Feb 2023, 11:32AM NGL Fine-Chem informs about disclosure 22 Feb 2023, 12:16PM NGL Fine-Chem - Quaterly Results10 Feb 2023, 6:14PM NGL Fine-Chem - Quaterly Results10 Feb 2023, 6:14PM NGL Fine-Chem informs about board meeting 30 Jan 2023, 12:22PM Ngl Fine-Chem informs about trading window closure28 Dec 2022, 3:30PM NGL Fine-Chem - Quaterly Results28 Oct 2022, 6:48PM NGL Fine-Chem - Quaterly Results28 Oct 2022, 6:48PM Ngl Fine-Chem informs about loss of share certificate13 Oct 2022, 4:56PM NGL Fine-Chem informs about analyst meet29 Sep 2022, 12:17PM Ngl Fine-Chem informs about loss of share certificate22 Sep 2022, 4:54PM NGL Fine-Chem informs about transcript of conference call20 Aug 2022, 10:31AM NGL Fine-Chem - Quaterly Results10 Aug 2022, 7:27PM NGL Fine-Chem - Quaterly Results10 Aug 2022, 7:27PM NGL Fine-Chem informs about certificate2 Jul 2022, 11:44AM NGL Fine-Chem informs about closure of trading window28 Jun 2022, 3:25PM NGL Fine-Chem informs about details of loss of certificate6 Jun 2022, 3:57PM NGL Fine-Chem informs about details of loss of certificate 30 May 2022, 1:49PM NGL Fine-Chem informs about non-applicability of large corporate entity13 May 2022, 2:42PM NGL Fine-Chem informs about investors conference call4 May 2022, 4:53PM NGL Fine-Chem - Quaterly Results2 May 2022, 6:47PM NGL Fine-Chem - Quaterly Results2 May 2022, 6:47PM

NGL Fine-Chem Stock Price Analysis and Quick Research Report. Is NGL Fine-Chem an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into NGL Fine-Chem and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. NGL Fine-Chem cash from the operating activity was Rs 31.8862 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. NGL Fine-Chem has a Debt to Equity ratio of 0.1441 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In NGL Fine-Chem , the EPS growth was -61.4926816809076 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, NGL Fine-Chem has OPM of 10.4394252006435 % which is a bad sign for profitability.
     
  • ROE: NGL Fine-Chem have a poor ROE of 9.31238066584121 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of NGL Fine-Chem is Rs 2710.95. One can use valuation calculators of ticker to know if NGL Fine-Chem share price is undervalued or overvalued.
Last Updated on:
Brief about NGL Fine-Chem

NGL Fine-Chem Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

NGL Fine-Chem Limited is a leading company in the chemical industry, specializing in the manufacturing and distribution of fine chemicals. With a strong presence in both domestic and international markets, NGL Fine-Chem Limited has established itself as a trusted name in the industry.

NGL Fine-Chem Limited - Share Price

Get real-time updates on NGL Fine-Chem Limited's share price, ensuring you stay informed and make well-informed investment decisions. Our pre-built screening tools allow you to easily track the performance of NGL Fine-Chem Limited's stock and analyze historical trends.

NGL Fine-Chem Limited - Balance Sheet

Analyze NGL Fine-Chem Limited's financial health through its balance sheet. Our premium features enable you to calculate the fair value of the company using various tools, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. These tools provide valuable insights for long-term stock investors seeking in-depth stock analysis.

NGL Fine-Chem Limited - Annual Report

Access NGL Fine-Chem Limited's annual reports on our website. These comprehensive documents provide a detailed overview of the company's performance, strategy, and outlook. With downloadable annual reports, you can study NGL Fine-Chem Limited's financials at your convenience and make informed investment decisions.

NGL Fine-Chem Limited - Dividend

Stay up-to-date with NGL Fine-Chem Limited's dividend announcements. Our platform allows you to easily track dividend history and projections, helping you assess the company's dividend yield and potential returns. For long-term investors seeking stable income streams, NGL Fine-Chem Limited's dividend information is a valuable resource.

NGL Fine-Chem Limited - Quarterly Result

Monitor NGL Fine-Chem Limited's quarterly performance through our platform. Explore the company's financials and assess its growth trajectory. Our premium features enable you to evaluate the fair value of NGL Fine-Chem Limited's stock using a variety of analytical tools, providing a comprehensive analysis for long-term investors.

NGL Fine-Chem Limited - Stock Price

Stay updated with real-time stock prices of NGL Fine-Chem Limited. Through our platform, you can easily track the stock's performance and analyze historical price movements. Our pre-built screening tools allow you to identify trends and make informed investment decisions with ease.

NGL Fine-Chem Limited - Price Chart

Visualize NGL Fine-Chem Limited's stock performance with interactive price charts. Our platform provides comprehensive price charts that enable you to identify patterns, trends, and potential opportunities. Long-term investors can utilize these charts to make well-informed decisions based on historical trends and future projections.

NGL Fine-Chem Limited - News

Access the latest news and updates about NGL Fine-Chem Limited through our platform. Stay informed about important developments that may impact the company's stock performance. Our curated news section ensures you have access to relevant and timely information, empowering you to make informed investment decisions.

NGL Fine-Chem Limited - Concall Transcripts

Gain insights into NGL Fine-Chem Limited's conference call discussions with our downloadable concall transcripts. These transcripts provide a comprehensive record of management's remarks, investor questions, and key takeaways. Stay informed about the company's strategic initiatives, performance updates, and future plans through these valuable resources.

NGL Fine-Chem Limited - Investor Presentations

Access NGL Fine-Chem Limited's investor presentations on our website. These presentations provide a detailed overview of the company's operations, financials, and growth strategies. Stay updated on NGL Fine-Chem Limited's achievements, market positioning, and future prospects through these informative presentations.

NGL Fine-Chem Limited - Promoters

Understand the key individuals behind NGL Fine-Chem Limited's success. Our platform provides detailed information about NGL Fine-Chem Limited's promoters, allowing you to assess their experience, expertise, and influence on the company's performance. Gain insights into the leadership team that drives NGL Fine-Chem Limited's growth and success.

NGL Fine-Chem Limited - Shareholders

Explore NGL Fine-Chem Limited's shareholder information and ownership structure. Understand the major stakeholders and their influence on the company's decision-making processes. Our platform provides valuable insights into the distribution of ownership, enabling you to assess the stability and governance structure of NGL Fine-Chem Limited.

With a commitment to serving long-term stock investors, NGL Fine-Chem Limited offers a comprehensive stock analysis platform. Through our pre-built screening tools and premium features, you can analyze the company's performance, assess fair value using various tools, and access essential resources such as annual reports, concall transcripts, investor presentations, and credit ratings. Stay informed, make informed investment decisions, and maximize your returns with NGL Fine-Chem Limited's stock analysis platform.

Read More
X